bohydrate-processing enzyme mechanisms and their potential
to act as suicide inhibitors, few sugar imines are known. In
the few cases that sugar imines have been synthesized they
have shown enhanced inhibitory properties over their fully
reduced counterparts.9 Indeed, nectrisine (FR-900483) 1
isolated from Nectria lucida is a known potent R-manno-
sidase and glucosidase inhibitor.10 The introduction of
hydrophobic aromatic or alkyl groups has also given rise to
novel sugar mimetics with enhanced potency (through
interaction with hydrophobic protein residue side chains) and
bioavailability (through altered membrane permeability) in
carbohydrate-processing systems.11 Typically the synthesis
of sugar mimetics bearing such additional substituents often
requires their introduction at an early stage in the synthesis;
however the synthesis of diverse arrays of aza-sugars would
ideally involve the elaboration of a late stage intermediate.
To address this problem and with the aim of creating libraries
for high throughput screening, we set ourselves the goal of
developing just such a late stage diversification. As our
synthetic strategy we have successfully combined (i) regio-
selective CdN imine formation with (ii) the irreversible
addition of organometallics to these late stage cyclic imine
intermediates (Scheme 1).
Remarkably, although the irreversible addition of orga-
nometallics to acyclic imines has been widely exploited,13
its application to cyclic imines has been scarce.14 Indeed,
such additions to polyhydroxylated imines have to date been
limited solely to iminoribitol 2. These elegant studies15 have
highlighted the synthetic potential of this method through
the addition of a variety of nucleophiles to 2 that allowed
the preparation of “immucillin” nucleoside analogues as
potential antimalarials.7 However the generality of this
methodology and in particular the scope of the imine
electrophile is unexplored. This communication reveals the
wide scope of this methodology, including its application to
the elaboration of 3 to prepare nectrisine analogues, the
elaboration of known model glycosidase inhibitors 1-deoxy-
nojirimycin (4, DNJ)16 and 1,4-deoxy-1,4-imino-L-rhamnitol
(5, DRAM),17 and the first examples of such additions to
cyclic ketimines.
To probe the breadth of (i) imines that could be synthe-
sized and (ii) the imine addition methodology we chose imine
targets 10, 11, 15, 18, 21, 22, 25 and 26 (Scheme 2). Simple
piperidinoimines 10 and 11 were readily prepared by
elimination of HCl with diazabicycloundecene (DBU) from
their corresponding N-chloro derivatives 8 and 9, which were
themselves prepared using N-chlorosuccinimide (NCS) in
Et2O. Polyhydroxylated sugar imines 15, 18, 21, 22, 25, and
26 were prepared in three contrasting ways to illustrate ready
preparation from different sources.
Scheme 1a
First, to illustrate the construction of a complete aza-sugar
motif from an unfunctionalized scaffold, racemic dihydroxy
iminothreitol 15 was prepared from 3-pyrroline 12 in seven
steps. Thus, N-protection, epoxidation,18 and hydrolysis gave
trans-diol 13,19 which after protecting group manipulation
afforded protected amine 14 in 36% overall yield. Chlorina-
tion of 14 using NCS followed by elimination with diaza-
bicycloundecene (DBU) gave target iminothreitol 15. The
(10) (a) Hibata, T.; Nakayama, O.; Tsurumi, Y.; Okuhara, M.; Terano
H. Ohsaka, M. J. Antibiot. 1988, 41, 296. (b) Kim, Y. J.; Takatsuki, A.;
Kogoshi, N.; Kitahara, T. Tetrahedron 1999, 55, 8353.
a Strategic stages: (i) regioselective imine formation; (ii) ir-
reversible addition of R1M, R2M, ....
(11) For representative examples, see: (a) Platt, F. M.; Neises, G. R.;
Karlsson, G. B.; Dwek R. A.; Butters, T. D. J. Biol. Chem. 1994, 269,
27108. (b) Murray, B. W.; Takayama, S.; Schultz J.; Wong C.-H.
Biochemistry 1996, 35, 11183. (c) Bleriot, Y.; Veighey, C. R.; Smelt, K.
H.; Cadefau, J.; Stalmans, W.; Biggadike, K.; Lane, A. L.; Mu¨ller, M.;
Watkins, D. J.; Fleet, G. W. J. Tetrahedron: Asymmetry 1996, 7, 2761. (d)
Butters, T. D.; van den Broek, L. A. G. M.; Fleet, G. W. J.; Kru¨lle, T. M.;
Wormald, M. R.; Dwek, R. A.; Platt, F. M. Tetrahedron: Asymmetry 2000,
11, 113.
(12) Some of this work was first presented at the 2nd EuroConference
on Carbohydrates in Drug Research, Estoril, Portugal, Sept 14-17, 2000.
(13) (a) Volkmann, R. A. In ComprehensiVe Organic Synthesis: Addi-
tions to C-X π bonds, Part 1; Schreiber, S. L., Ed.; Pergamon: Oxford,
1991; pp 355-396. (b) Bloch, R. Chem. ReV. 1998, 98, 1407. (c) Kobaysahi,
S.; Ishitani, H. Chem. ReV. 1999, 99, 1069.
(14) Elegant Strecker-type additions of cyanide to cyclic imines have
been reported but due to their reversible nature rely on product stability for
stereocontrol. See ref 9a for a prime example.
(15) (a) Evans, G. B.; Furneaux, R. H.; Gainsford, G. J.; Schramm V.
L.; Tyler, P. C. Tetrahedron 2000, 56, 3053. (b) Furneaux, R. H.; Limberg,
G.; Tyler P. C.; Schramm, V. L. Tetrahedron 1997, 53, 2915. (c) Horenstein,
B. A.; Zabinski R. F.; Schramm, V. L. Tetrahedron Lett. 1993, 34, 7213.
(16) Inouye, S.; Tsurouka, T.; Ito, T.; Niida, T. Tetrahedron 1968, 24,
2125.
(17) Davis, B.; Bell, A. A.; Nash, R. J.; Watson, A. A.; Griffiths, R. C.;
Jones, M. G.; Smith, C.; Fleet, G. W. J. Tetrahedron Lett. 1996, 37, 8565.
(18) Li, Q.; Wang, W.; Berst, K. B.; Claiborne A.; Hasvold, L. Bioorg.
Med. Chem. Lett. 1998, 8, 1953.
Thus, this Letter describes the synthesis of novel sugar
imines of double utility not only as attractive inhibitor targets
in their own right but also as scaffolds that may be readily
and diversely elaborated. In this way we have been able to
construct sugar mimics bearing one or both of two structural
elements of potentially enhanced potency: (i) endocyclic Cd
N unsaturation and (ii) a hydrophobic group.12
(6) Fan, J. Q.; Ishii, S.; Asano N.; Suzuki, Y. Nat. Med. 1999, 5, 112.
(7) (a) Li, C. M.; Tyler, P. C.; Furneaux, R. H.;. Kicska, G.; Xu, Y. M.;
Grubmeyer, C.; Girvin, M. E.; Schramm, V. L. Nat. Struct. Biol. 1999, 6,
582. (b) Miles, R. W.; Tyler, P. C.; Evans, G. B.; Furneaux, R. H.; Parkin,
D. W.; Schramm, V. L. Biochemistry 1999, 38, 13147.
(8) (a) Sinnott, M. L. Chem. ReV. 1990, 90, 1171. (b) Legler, G. AdV.
Carbohydr. Chem. Biochem. 1990, 48, 319 (c) Stu¨tz, A. E. Angew. Chem.,
Int. Ed. Engl. 1996, 35, 1926 (d) Heightman T. D.; Vasella, A. T. Angew.
Chem., Intl Ed. 1999, 38, 750.
(9) (a) Takayama, S.; Martin, R.; Wu, J. Y.; Laslo, K.; Siuzdak, G.;
Wong, C.-H. J. Am. Chem. Soc. 1997, 119, 8146. (b) Wong, C.-H.;
Provencher, L.; Porco, J. A.; Jung, S. H.; Wang, Y. F.; Chen, L. R.; Wang
R.; Steensma, D. H. J. Org. Chem. 1995, 60, 1492.
(19) Huang H.; Wong, C.-H. J. Org. Chem. 1995, 60, 3100.
104
Org. Lett., Vol. 4, No. 1, 2002